Catalyst Clinical Research Acquires Aptus Clinical to Accelerate European Expansion, Broaden Client Services, and Enhance Patient Impact

Today, Catalyst Clinical Research, a market-leading provider of clinical research services, announced a strategic acquisition of Aptus Clinical to expand the geographic reach of the two companies, and to enhance patient access to advanced, life-changing therapies. Together, the two entities will become one multi-region clinical research organization with an accelerated growth trajectory in both the...

Using wearables and AI to support the monitoring of COVID-19 patients

Development of Novel Wearables and AI Capabilities to Support the Monitoring of COVID-19 Patients A Model for the Future? Monitoring COVID-19 PatientsUsing Novel Wearables Technologies and AI Capabilities The ChallengeAs the COVID-19 pandemic developed, it soon emerged that hospital staff faced significant challenges in identifying/predicting which patients would need critical care. This became increasingly important...

Pharmacy, Disability and Me

Pharmacy, Disability and Me Pharmacy, Disability and MeAnita Cawley our Chief Governance Officer and Vice Chair, Pharmacist Support Being born with cerebral palsy posed many challenges but my disability was never going to define me. Interest in pharmacyMy disability meant regular interactions with healthcare professionals from a young age, and my use of medicines sparked...

COSMIC-19 Abstract Published in the British Journal of Anaesthesia

COSMIC-19 Abstract Published in the British Journal of Anaesthesia COSMIC-19 Abstract Published in the British Journal of Anaesthesia An abstract that focuses on COSMIC 19, a project funded by the iMATCH consortium, has been published in the British Journal of Anaesthesia (BJA). The abstract evaluated how the use of ‘continuous vital signs’ monitors could offer...

Trial of wearable health technology for cancer patients opens

Trial of Wearable Health Technology for Cancer Patients Opens EMBRaCE - Enhanced Monitoring for Better Recovery and Cancer Experience A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment. The commercially-available health sensors and devices produce a digital fingerprint of vital signs that...

Aptus Strengthens Commercial and Clinical Team

Aptus Clinical is delighted to strengthen and expand its commercial and clinical teams with four new employees. Within Clinical Services, Aptus has welcomed Ms. Noriega as CRA Manager, Mohamed Jama and Beauty Mutandari as  CTAs and promoted Kristin Cope to CTA manager. The commercial team has also introduced Amy Cheney, in a new role as Marketing...

Project management: UK Biotech

Project Management UK Biotech Delivering a Phase II European StudySupporting with Senior Project Manager The ChallengeAptus Clinical was approached by a UK Biotech to supply a Senior Project Manager to oversee a Phase II Europe wide study being delivered by a major CRO The SolutionA highly-qualified Project Manager was recruited for this role by Aptus...

Clinical operations team: AstraZeneca

Clinical Operations Team AstraZeneca Delivering Global StudyPhase IIb BEECH The ChallengeAptus Clinical were asked by AstraZeneca (AZ) to provide a clinical operations team to deliver their global Phase IIb BEECH study in 11 countries The SolutionAptus Clinical efficiently supplied five highly experienced and skilled clinical operations professionals to undertake this work The OutcomeWorking with AZ...

Aptus Clinical announces the first patient has been dosed in the Artelo Biosciences’ CAReS Phase 1b/2a study in cancer anorexia

Aptus Clinical, as the full service CRO provider for the Phase 1b/2a Cancer Appetite Recovery Study (CAReS), has assisted Artelo Biosciences in the planning and running of this important study which investigates the potential for ART27.13 (a peripherally synthetic cannabinoid agonist), to alleviate anorexia associated with cancer, a condition with significant unmet need and no...

Scroll to top
Cookie Consent with Real Cookie Banner